Research/Clinical Trials

Pain Diagnostics and Interventional Care advances the field of pain medicine through appropriate clinical and basic science research. Research and education are crucial components of the Pain Diagnostics and Interventional Care mission. To learn more about research opportunities including clinical trials, please contact our office and ask to speak to our research coordinator.

TARGET Study- Dorsal Root Ganglion (DRG) stimulation for the treatment of Complex Regional Pain Syndrome (CRPS)

Abbott, formerly St. Jude Medical, is conducting a phase IV, post-market, clinical trial for DRG stimulation. The therapy is FDA approved for Complex Regional Pain Syndrome (CRPS), formerly known as Reflex Sympathetic Dystrophy (RSD).

The phase III clinical trial, known as the ACCURATE study, showed that DRG stimulation was effective in 93.3% of patients.

To learn more about the TARGET study click here.

Our site is one of only a few sites in the greater Pittsburgh area. Enrollment for this study is open.

Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation

Medtronic is conducting a study to evaluate the efficacy of spinal cord stimulation (SCS) therapy for low back and leg pain relief using high dose (HD) stimulation parameters delivered to neural targets identified during current commercial trial stimulation procedures.

This is a prospective, single-arm, multi-center study.

To learn more about the Vectors study click here.

Enrollment for this study is open.